News
-
Sabril substitution
Monday | Sep 18 2023THE TGA is informing pharmacists that due to the shortage of epilepsy medication, vigabatrin (Sabril), it has approved overseas-registered vigabatrin tablets under section 19A of the Therapeutic Goods Act 1989.
-
Patient ‘belittled’
Monday | Sep 18 2023SYDNEY comedian and endometriosis sufferer Anna Dooley was humiliated after a pharmacist allegedly "belittled" her as she tried to fill a prescription for painkillers, Yahoo News Australia has reported.
-
Product recall
Monday | Sep 18 2023LAST week, Felton Grimwade & Bosisto's recalled certain batches of Euky Bear Warm Steam Vaporiser - Humidifier because the enclosed heating element can overheat.
-
Reliable relief
Monday | Sep 18 2023SFI Health - home of Flordis, is promoting Femular Forte, a product that aims to provide multi-symptom relief to people experiencing menopause.
-
Dementia Week
Monday | Sep 18 2023DEMENTIA Action Week 2023 is currently on (18-24 Sep), with World Alzheimer's Day coming up this Thu.
-
‘Superjab’ coming
Monday | Sep 18 2023AUSTRALIANS will be eligible for a 'superjab' to protect them from both COVID and the flu by 2026 thanks to Moderna, The Weekend Australian has reported.
-
CW appoints new head of digital strategy
Monday | Sep 18 2023CHEMIST Warehouse has appointed Leteesha Serzycki as Head of eCommerce and Digital Experience, effective from today.
-
Tas scope is set to grow
Friday | Sep 15 2023TASMANIAN Health Minister Guy Barnett announced yesterday that pharmacists in the state will soon be able to prescribe medicines for aged care patients, under a new pilot program, following the release of recommendations from the Review of Tasmanian Pharmacists' Scope of Practice, which have been accepted by the state gov't in full.
-
Epic’s pay deal backed by PPA in Qld
Friday | Sep 15 2023UNION members have been successful in negotiating an average 13.8% pay rise over three years for pharmacy staff employed by Epic Pharmacy Services in Qld, with some staff set to receive a pay increase of over 20% in the first year alone.
-
Gardasil’s new indication approved
Friday | Sep 15 2023CSL Seqirus' Gardasil 9 (human papillomavirus 9-valent vaccine, Recombinant) has now been approved by the TGA for use in males aged nine to 45 years, for the prevention of anal cancer, pre-cancerous or dysplastic lesions, external genital lesions and infections caused by nine HPV types.
